News Catch-Up: Last week, #MeridaBiosciences emerged from #ThirdRockVentures with $121 million in first-round financing for a pipeline of drugs for #autoimmunediseases, headed by a Graves' disease candidate.

pharmaphorum.com/news/merida-...

Funding Raises: #CrusoeEnergySystems $225M Debt; #Heartflow $215M Series F; #BasePower $200M Series B; #Tailscale $160M Series C; #SandboxAQ $150M Series E; #Enpal €110 M Series E; #MeridaBiosciences $121M Series A; #Rescale $115M Series D; #Nuro $106M Series E